Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

growth may sustain damage between the gut and blood vessels

The hypothesis proposes that sustain a gut–blood vessel by generating surfaces for further . Continued damage transfer after and restoration of initial would reject this mechanism.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 5 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionHeart and blood vessels

Ageing mechanism

Main connectionExtracellular matrix and tissue mechanics

Direction

Kind of knowledge gap

No current scientific result answers this requirement.Void gap

A double ring marks the main placement where a group contains several values.

Lens
Mineral nucleation and growth
Goal
Затухание взаимного усиления возрастных повреждений
Competing hypotheses
3
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
10 / 10Completeness of the answer
6 / 10Novelty of the idea
10 / 10Few new entities
9 / 10Decisive experiment
6 / 10Silver-bullet potential
5 / 10Support from research
Poster: Calcium phosphate growth sustains damage
PosterOpen the sheet full size2026-09-30

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Mechanics and load

    mineral growth

    The growth of mineral in particles within the extracellular environment

    Where this hypothesis actsMetastable extracellular conditions during ageing, linking vascular damage and impaired intestinal repair

    Hypotheses on this target 4
    Calcium phosphate mineral growthInhibition. Hypotheses on this target 33Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Remodelling. Hypotheses on this target 0Load normalisation. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition3
    • Activation
    • Function preservation
    • Remodelling
    • Load normalisation
    • Direct measurement

    What is proposed

    Inhibition

    Temporarily suppress mineral growth to interrupt continued particle formation

    With whatNot stated in the record

    HowInhibit mineral growth in one causal link and remove remaining crystallization centres; selectively dissolve the mineral phase of the returned fraction

    Possible result

    Possible sustained interruption of particle formation and the resulting cycle of tissue damage

    From the recordВременное подавление роста минерала в одном причинном звене должно прекратить воспроизводство частиц; после удаления оставшихся центров петля может устойчиво затухнуть.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growth
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Damage in the gut and blood vessels might keep renewing itself after the original injury has passed. The unexpected move is to propose that tiny preserve the ability to restart damage even when the surrounding calcium and phosphate concentrations are unchanged. This is a hypothesis generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. Initial injury exposes more surfaces, the boundaries around cells, on which mineral could begin forming.
  2. grows at those starting sites and forms particles containing mineral and protein.
  3. The particles are proposed to damage blood vessel cells, exposing further surfaces for particle formation.
  4. Blood vessel damage is proposed to impair gut repair, making the gut another source of particle-forming surfaces.
  5. The system is proposed to switch from damage that fades after an injury to damage that generates enough new particles to sustain itself.
  6. Surviving are proposed to preserve this cycle even at unchanged calcium and phosphate concentrations.
  7. Temporary suppression of mineral growth, followed by removal of remaining , is proposed to switch the system back to damage that subsides.
A picture for it

A fire can look extinguished while embers remain ready to ignite fresh fuel. Removing the embers changes what happens next even if the amount of fuel stays the same.

Where the picture breaks: Mineral growth is not combustion, and this picture does not establish that mineral particles generate further injury or that gut and blood vessel damage can sustain each other.

  1. Master questionstep 01 of 04

    A treatment aimed at a shared cause of age-related damage could benefit several body systems because their damage processes may reinforce one another.

    Rests on: The goal is to identify a shared causal link through which one intervention could reduce several forms of age-related damage.

    Assumption

    The search assumes that at least some mutually reinforcing damage processes share a causal link that can be targeted for benefit across systems; the goal does not establish that such a target exists.

  2. Goal pillarstep 02 of 04

    Age-related damage should become less able to amplify damage elsewhere in the body.

    Rests on: The master question explicitly identifies mutual reinforcement between damage processes as a reason to seek a shared intervention.

    Stated in the chain
  3. Gap questionstep 03 of 04

    Damage passing between tissues might have a beyond which it keeps itself going; interrupting one link might bring lasting recovery rather than merely reduce the day's burden.

    Rests on: The preceding goal supplies the focus on mutual reinforcement. This stage asks whether that reinforcement can sustain itself and whether interrupting it can produce lasting recovery; neither outcome is presented as established.

    Stated in the chain
  4. Hypothesisstep 04 of 04

    , a mineral made from calcium and phosphate, is proposed to grow into damaging particles on surfaces exposed by injury. Damage to blood vessels would impair gut repair, and the injured gut would supply more surfaces for particle formation. Remaining would keep the cycle ready to restart; temporarily blocking growth and removing those might let it die out.S8S4

    Rests on: The gap question supplies the search for a self-sustaining cycle. Arteriosclerosis, Thrombosis, and Vascular Biology (2024, S8) describes conditions in which an existing can support crystal growth, but does not establish the proposed gut–vessel cycle. The Clinical Calcium abstract (2014, S4) reports that , particles containing and protein, can cause cell damage, but does not establish the proposed sequence of tissue injury and renewed particle formation.

    Supported by literature

What is carried, and what is not. Screened sources speak to three component processes: growth from existing , particle-related cell damage, and inhibition of . For the third, the Advances in Chronic Kidney Disease abstract (2018, S3) reports that magnesium impairs , but does not show lasting shutdown of a damage cycle; none of the supplied sources establishes the proposed sequence end to end.S3

Where the reasoning is carried by something unstated · 1
  • Master question. The search assumes that at least some mutually reinforcing damage processes share a causal link that can be targeted for benefit across systems; the goal does not establish that such a target exists.
How a result here could mislead · 3
  • Damage after adding could reflect injury caused by the added particles themselves rather than continuing production of new damaging particles. What closes it: The test must distinguish newly formed particles from the original addition and follow repeated injury over time. Comparisons must include the proposed particles whose growth is suppressed while their size and protein coating remain comparable.
  • Loss of damage transfer after dissolving mineral could be attributed to mineral removal when the treatment instead changed the surrounding fluid or other damaging material carried with the particles. What closes it: The proposed controls for acidity, dissolved-particle concentration and must be verified, along with restoration of calcium and phosphate concentrations. The comparison must establish that the treatment selectively removed mineral rather than also removing or disabling other candidate carriers of damage.
  • Continued damage after blocking cell division or removing , oxidized fat molecules implicated in a rival damage cycle, could be read as excluding those rivals even if the interventions did not adequately affect their targets. These comparisons also do not directly test the rival based on changing proportions of cells that contribute to tissue repair. What closes it: Actual suppression of cell division and removal of must be measured alongside preserved mineral growth. Separating the repair-contribution rival requires measuring or controlling the proportions and relative survival of the proposed cell types; that comparison is not specified in the supplied test outline.

What would make this wrong. The claimed dependence on mineral would be contradicted if damage kept transferring and renewing itself after verified selective removal of the mineral component, with surrounding conditions restored and no remaining growth-capable . Its distinctive restart prediction would also fail if verified growth-capable produced no sustained new particle formation or repeated damage under the proposed matched conditions. The supplied material gives no duration or quantitative criterion for deciding when persistence or shutdown has occurred.

What it would change. If this held, a shared treatment target could be the production and persistence of damaging mineral particles, making removal of surviving relevant alongside control of current calcium and phosphate concentrations. Work seeking a broad intervention against aging would then need to distinguish temporary reductions in damage from a lasting interruption of its reproduction. The proposed first tests concern aged models especially prone to particle formation, so success would not establish the mechanism in ordinary aging or show longer life. The named outcome is not defined in the supplied material, so its proposed stabilization cannot be translated into a specific measured benefit.

Sources read · 6

3 literature searches, 5 full texts, 5 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

Accelerated calciprotein crystallization time (T50) is correlated with impaired lung diffusion capacity in systemic sclerosis. · Frontiers in immunology · 2024

“These are able to aggregate and form primary calciprotein particles (CPP1), which can further mature into secondary CPP2 ( ).”

Does not settle: Источник описывает образование и созревание кальципротеиновых частиц и их связь с минеральным буферированием сыворотки. Он не устанавливает порог межтканевого повреждения, роль мембранных поверхностей кишечника или сосудов как центров кристаллизации, самоподдерживающуюся петлю между кишечником и сосудами, зависимость исхода от сохранённых центров при одинаковых концентрациях кальция и фосфата либо устойчивое прекращение образования частиц после временного подавления их роста.

S2Partly answers it

Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients. · American journal of nephrology · 2018

“Shortened T50, as well as reduced fetuin-A levels, ostensible promoters of vascular calcification, remained associated with greater risk for CVD outcomes, after adjustment for major CVD risk factors, measures of kidney function and damage, and KTR clinical characteristics and demographics, in a large, multiethnic cohort of long-term KTRs.”

Does not settle: This observational study in stable kidney transplant recipients does not establish that calcium-phosphate particle growth causes vascular or gut injury, a self-sustaining gut–vascular feedback loop, persistence of crystallization centers at equal calcium and phosphate concentrations, or that transient mineral-growth suppression can extinguish such a loop or stabilize SPV_1.

S3Partly answers itAbstract only

Magnesium and Progression of Chronic Kidney Disease: Benefits Beyond Cardiovascular Protection? · Advances in chronic kidney disease · 2018

“Magnesium impairs the crystallization of calcium phosphate-more specifically, the maturation of calciprotein particles.”

Does not settle: Источник оставляет открытыми межтканевую петлю между кишечником и сосудами, роль мембранных поверхностей и сохраняющихся центров кристаллизации, порог повреждения, одинаковые концентрации кальция и фосфата, а также устойчивое затухание процесса после подавления минерализации.

S4Partly answers itAbstract only

[New Developments in CKD-MBD. Why is phosphate overload harmful?]. · Clinical calcium · 2014

“CPPs are highly bioactive ligands that induce cell damage and innate immune responses. Serum levels of CPPs are increased in CKD patients and independently associated with vascular calcification and chronic inflammation.”

Does not settle: This abstract does not establish the proposed gut–vascular feedback loop, nucleation on damaged membranes, persistence of crystallization centers at equal calcium and phosphate concentrations, or whether transient mineral-growth suppression can durably stop particle reproduction or stabilize SPV_1.

S7Partly answers itAbstract only

Effects of calciprotein particles on EMT induction in an in vitro 3D-cultured proximal tubule epithelial cell model of CKD. · BioFactors (Oxford, England) · 2025

“3D-cultured PTECs under CKD-inducing conditions by CPPs were associated with epithelial-mesenchymal transition (EMT), mediated by transforming growth factor-β1 (TGF-β1), with notable changes in early EMT marker expression.”

Does not settle: Источник описывает действие кальципротеиновых частиц на почечные проксимальные канальцевые эпителиальные клетки в трёхмерной модели in vitro. Он не устанавливает межтканевую петлю между кишечником и сосудами, порог роста частиц, роль сохранившихся центров кристаллизации, повреждение сосудистых клеток или устойчивое затухание после подавления минерализации.

S8Partly answers it

Phosphate in Cardiovascular Disease: From New Insights Into Molecular Mechanisms to Clinical Implications. · Arteriosclerosis, thrombosis, and vascular biology · 2024

“Circulating phosphate, while under the levels of spontaneous precipitation with calcium, is above the solubility of bulk bone mineral (hydroxyapatite), which will readily sustain crystal growth if nucleated .”

Does not settle: Источник не устанавливает порог межтканевого повреждения, роль кишечного повреждения или мембранных поверхностей как центров минерализации, самоподдерживающуюся петлю между кишечником и сосудами, исход при одинаковых концентрациях в зависимости от сохранившихся центров, а также эффект временного подавления роста минерала на SPV_1.

The gap this hypothesis explains

Nothing is known here: the question has not been asked of this system.

Can breaking one link cross a damage and restore aging tissues, beyond simply reducing daily harm?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Существует ли у стареющего организма , пересечение которого воздействием на одно звено вызывает устойчивое восстановление, и как отделит этот механизм от общей ?

What this question is asking

The question asks whether damage passing between tissues can become self-sustaining, and whether interrupting one causal link can switch an aging organism back toward lasting recovery. It assumes that interacting processes form a complete feedback loop, in which damage eventually feeds back to reinforce its own cause; the supplied material does not establish that full loop. The proposed signs of recovery are shrinking repeated peaks of damage, restoration of a protective tissue barrier within the first day, and a delay between responses in different systems that stays within specified limits across successive daily cycles. The decisive distinction is whether recovery follows from stopping the loop from sustaining itself or simply from reducing the total harmful burden each day. The supplied material names linked-organ and timing measurements as available tools, but does not describe their validation, the relevant barrier, or the acceptable timing limits.

What the terms mean
Self-sustaining damage
Damage whose consequences generate enough further damage to keep the process operating. The question asks whether this happens between tissues, rather than merely whether injury persists while an external harmful exposure continues.
Feedback loop or positive feedback
A chain of effects that returns to influence its starting point; positive feedback reinforces the initial change. A connection from one tissue to another establishes only part of a loop unless a returning influence is also established.
Causal link
A connection in which changing one process changes a downstream process. The proposed intervention targets one such connection within the claimed .
Damage threshold or tipping point
A boundary between different patterns of behavior, here damage that fades and damage that maintains itself. The supplied question proposes such a boundary but gives no established value or measurement for it.
Daily harmful burden
The total harm imposed over a day, as invoked by the question. The supplied material does not specify its components or how they would be combined into a measurement.
Tissue barrier and gut barrier
A layer of cells that controls movement between compartments, such as between the gut’s contents and the rest of the body. Barrier function varies in degree; a leaky gut means impaired control, rather than necessarily a complete physical break.
Delay between system responses
The elapsed time between a change in one biological system and a corresponding change in another. The question treats stable timing over daily cycles as a recovery criterion but does not provide acceptable limits.
Linked-organ and timing measurements
Tools that the supplied gap description says can investigate connections between organ systems and the timing of their responses. Their construction, capabilities, and validation are not supplied.
Liver scarring
Accumulation of scar tissue in the liver, also called hepatic fibrosis. S2 describes interacting injury processes that promote it, which provides a narrower example of self-amplifying damage.
Inflammation
A biological response to injury or threat that can also contribute to damage when it persists or becomes excessive. The sources discuss it in several settings, which do not automatically establish the same mechanism.
Regulated cell death
Cell death carried out through an organized biological process. S3 concerns a enabling such a process within cells, not a demonstrated recovery between tissues.
Macrophages
Immune cells involved in responding to injury and clearing material. They are the cellular setting identified in the supplied summary of S3.
Atrial fibrillation
An irregular heart rhythm involving the heart’s upper chambers. Susceptibility to this rhythm is the outcome reported in S5, rather than a measurement of overall recovery from aging.
Signaling component
A molecule or biological process that helps transmit an effect within or between cells. S5 reports benefits from blocking particular components of the gut–heart connection.
Cellular senescence
A cell state commonly characterized by a lasting halt in division and changes in cell function. It is not synonymous with aging of an entire organism; S7 concerns this state in the intestine.
Polystyrene particles
Small pieces of a type of plastic. Their exposure, together with particular dietary conditions, defines the injury setting described in S7.
Microorganism communities
Groups of microscopic organisms living in a particular environment, including within or on the body. S6 discusses how aging-related changes in these communities connect with bodily dysfunction.
Coronavirus disease 2019
The infectious disease discussed in S8. Its reported progression provides a different disease context for barrier failure and multiple-organ dysfunction.
Lactylation
A chemical modification of proteins. S9 discusses its inhibition as a way of suppressing a reinforcing pathway associated with brain inflammation.
Microglia
Immune cells in the brain. Excessive activation of these cells is part of the inflammation mechanism described in S9.
Alzheimer’s disease model
A research system representing selected features of a disease that damages brain function. Findings in that model do not by themselves establish effects throughout an aging organism.
What the question takes for granted
Premise only partly supported
Interacting damage processes in an aging organism form a complete, self-amplifying loop between tissues that can be distinguished from the total daily harmful burden; linked-organ and timing measurements already provide tools for investigating it.

The assumption is that injury can pass between tissues and return to worsen the injury that started the sequence. A protective tissue barrier is one proposed part of this sequence, while the time between responses in different systems is a proposed measurement of their connection. If this assumption held, improvement after interrupting one connection could potentially be interpreted as a change in the cycle itself, rather than only as less harm entering the system.

The read sources support narrower elements: S2 describes a self-amplifying network in chronic liver injury, S5 reports that interventions affecting the gut–heart connection reduce susceptibility to an abnormal heart rhythm in mice, and S9 reports suppression of a reinforcing process within a brain-disease model. These do not establish a complete self-sustaining loop between tissues in an aging organism. S4 explicitly presents the mechanism as a hypothesis. None of the supplied excerpts validates the named measurement tools or establishes a way to separate loop interruption from reduced daily harmful burden.S2S4S5S9

The same question asked without the part nothing read establishes:

  • Does interrupting one causal connection between tissues in an aging organism produce lasting recovery through a damage , beyond the effect of reducing total daily harm?
  • Do connected tissues in an aging organism continue to reinforce one another’s damage after the initiating harmful burden subsides?
What turns on the answer
  • A permits lasting recovery If interrupting one link reduces reinforcement below the level needed to sustain damage, each successive round of damage would weaken. Recovery across connected tissues would then reflect a change in the feedback process, provided that reduced daily harm alone does not explain it.
  • Improvement reflects reduced daily harm If the intervention reduces the harmful burden without changing a self-sustaining process, less damage could occur while that reduction continues. The improvement would not establish that a was crossed or that recovery would persist when the burden returned.
  • One interrupted link does not restore the system If damage continues to sustain itself despite interruption of the chosen link, improvement in one tissue would not establish recovery across the connected tissues. That outcome would leave the proposed single-link route to lasting recovery unestablished, without by itself ruling out every possible damage .
Why it matters

Under the proposed mechanism, damage in one tissue affects another, and a returning effect reinforces damage in the first tissue. If that reinforcement can maintain damage, reducing an initiating harmful exposure might leave the cycle operating. Interrupting an essential link could then allow damage to subside across the connected tissues, but lasting recovery is a further claim that needs its own evidence. Mistaking a temporary reduction in daily harm for this transition would turn a limited improvement into an unsupported claim that the organism had entered a durable recovery state.

What is already established

RL-1 и RL-2 позволяют исследовать связи, но не установлен.

What would have to be true

Повторные пики повреждения затухают; восстанавливается в первые сутки, остаётся в заданных пределах при последовательных суточных циклах.

What is missing

Отсутствует экспериментально установленный переход между затухающим и самоподдерживающимся повреждением, управляемый одним .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

задаётся образованием и ростом в . Первичное повреждение увеличивает число , пригодных для . Возникающие повреждают и создают новые поверхности для дальнейшего образования частиц. ухудшает восстановление кишечника, который становится дополнительным источником таких поверхностей. При одинаковых текущих концентрациях кальция и исход зависит от сохранившихся . Временное подавление роста минерала в одном должно прекратить воспроизводство частиц; после удаления оставшихся центров петля может устойчиво затухнуть. Предполагаемое общее воздействие стабилизирует через прекращение образования физически повреждающего материала.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При одинаковых , , и внешних нагрузках малая добавка запускает длительное образование новых частиц и повторные пики повреждения. Частицы с подавленной способностью к росту при сопоставимых размере и такого эффекта не дают. прекращает передачу повреждения после восстановления исходных . Добавление новых центров вновь запускает цикл после отмены вмешательства. Зависимость от сохраняется при подавлении деления клеток; при сохранённой одно устранение устойчивого выключения не обеспечивает.

Would tell it apart from at least one rival. The text predicts observable particle formation, recurring damage, and cessation or resumption of damage transmission under specified conditions. These qualitative comparisons are measurable. No rival prediction was supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Возможны , определение , измерение и с очищенными частицами. Контроль должен исключать изменение , и при растворении . В первую очередь проверяют старые модели с повышенной склонностью к образованию частиц; распространение результата на обычное старение требует отдельного подтверждения.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При одинаковых , , и внешних нагрузках малая добавка запускает длительное образование новых частиц и повторные пики повреждения. Частицы с подавленной способностью к росту при сопоставимых размере и такого эффекта не дают. прекращает передачу повреждения после восстановления исходных . Добавление новых центров вновь запускает цикл после отмены вмешательства. Зависимость от сохраняется при подавлении деления клеток; при сохранённой одно устранение устойчивого выключения не обеспечивает.

  • What would separate them

    Repair-driven cell division may sustain a cycle of damage between the gut and blood vessels predicts: В связанной модели кишечника и сосудистой ткани после удаления исходного новые очаги повреждения преимущественно возникают в , вступивших в деление после первичного эпизода. Обратимая только в на один цикл восстановления прекращает последующие волны в обеих тканях. Эффект сохраняется после возобновления деления и при прежней . Численность первоначальных при этом может оставаться прежней. Если повреждение продолжает распространяться при подтверждённой , а прекращается при подавлении или образования минеральных частиц, гипотеза отвергается в пользу соответствующего соперника.

  • What would separate them

    Selection against repair-contributing stromal cells may sustain damage across tissues predicts: При одинаковых общей численности клеток, начальном повреждении и исходная доля определяет противоположные долгосрочные траектории. Ниже независимо оценённого порога эта доля уменьшается, выше него возрастает; вслед за этим соответственно усиливаются или затухают повторные повреждения. Краткое вмешательство даёт устойчивый результат только при пересечении . Одинаковое временное торможение деления обеих , сохраняющее их соотношение, устойчивого переключения не вызывает. При экспериментально постоянном составе клеток предполагаемый переход исчезает, даже если продолжается.

  • What would separate them

    A lipid oxidation chain may sustain damage between gut and vascular tissue predicts: каждого тканевого звена показывает последовательное образование новых сначала в , затем в исходной после возврата . Повреждающая активность регенерируется при , превышая остаточную активность первоначального материала с учётом его . Она сохраняется при и отсутствии минеральных частиц, но прекращается после избирательного в . на время исчезновения этой активности обеспечивает устойчивое восстановление после повторного соединения. Если эффект требует или переносится очищенной при удалённых , гипотеза отвергается.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.